NIH-funded research R01 grant

How the brain's fuel signals relate to Alzheimer's and aging

Official title: Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain

Funded at Buck Institute for Research on Aging · NIH-11449229 · Data updated 2026-11-12

A researcher is studying how ketone signals like beta-hydroxybutyrate affect aging brains and Alzheimer’s disease, with the goal of finding new ways to support brain health.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBuck Institute for Research on Aging
NIH-funded
Lab location1 site (Novato, United States)
Project startJune 1, 2020
Project endMay 31, 2031
Funding year2026
Award (this year)$806,483
NIH project number2R01AG067333-06
Project IDNIH-11449229 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 years or older who have or are at risk for Alzheimer's disease or aging-related brain changes, potentially including individuals contributing human samples or data.

Less likely to help

As this is a mechanistic study, some participants may not directly benefit if they do not have the condition or meet the specific study criteria.

What this research studies

This project looks at how aging and Alzheimer’s disease change brain metabolism and signaling, focusing on a ketone body called beta-hydroxybutyrate. The study uses human-relevant aging and Alzheimer’s models to understand how metabolic signals influence brain cells, inflammation, and gene expression. By exploring how ketone signals interact with brain pathology, the work aims to identify potential targets for therapies that support aging brains and delay dementia progression. The research blends animal and cellular models with human biology to map how metabolic states affect brain aging.

Why it matters

Potential benefit: If successful, this work could reveal metabolic targets that help slow brain aging and progression of Alzheimer’s disease.

How similar studies have gone: Prior work suggests metabolic signals like ketone bodies influence aging and brain health, supporting potential translational relevance.

Where this research is happening

  • Buck Institute for Research on Aging
    Novato, United States
    Active

Researchers

  • Principal investigator: Newman, John C — Buck Institute for Research on Aging
  • Study coordinator: Newman, John C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.